Australian Clinical Labs Share Price and Company Fundamentals
Last traded: Today at 6:11 AM
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Key Metrics
PE ratio
5.09
PB ratio
3.91
Dividend yield
11.78%
Beta
-
Market cap
-
Enterprise value
-
Company profile
| Primary activities | Provision of pathology services |
|---|---|
| Industry / Sector | Diagnostics & Research / Healthcare |
| Full time employees | 5400 |
| Website | https://www.clinicallabs.com.au |
| Mailing address | 1868-1892 Dandenong Road Clayton VIC 3168 Australia |
| Phone / Fax | 61 3 9538 6777 / 61 3 9538 6777 |
| Share registry | LINK MARKET SERVICES LIMITED |
Dividends
More: Australian Clinical Labs Dividend history, yield and payout ratio
Dividend yield
11.78%
Dividend amount
$0.53
Payout ratio
13.57%
Australian Clinical Labs paid $0.53 dividend and the ex-dividend date was 23 Aug 2022.The dividend payout ratio is 13.57%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ACL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
ACL's forward dividend amount is $0.82 and the forward dividend yield is 18.22%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Aug 2022, following are the company executives and directors listed on Australian Clinical Labs.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Melinda McGrath | CEO & Exec. Director | 1.81M | |
| Mr. James Davison | Chief Financial Officer | 936.09k | |
| Mr. Anthony Friedli | Chief Operating Officer | ||
| Mr. Sean Jackson | Chief Information Officer | ||
| Mr. Joe Geran | National Marketing Director | ||
| Associate Prof. Tony Landgren | National Medical Director & Chief Pathologist | ||
| Mr. Chris Brownlow | Chief Exec. Officer of New South Wales & Australian Capital Territory | ||
| Ms. Shae Seymour | Chief Exec. Officer of Western Australia | ||
| Mr. Eric Swayn | Chief Exec. Officer of South Australia & Northern Territory | ||
| Ms. Eleanor Padman B.A., FCIS | Company Sec. |
Profitability and management effectiveness
Profit margin
17.90%
Operating margin
27.52%
Return on assets
30.79%
Return on equity
113.46%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Australian Clinical Labs is and its enterprise value is .
Companies similar to Australian Clinical Labs (ACL)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Australian Clinical Labs (ASX:ACL) Frequently Asked Questions
1. What is Australian Clinical Labs's Stock Symbol?
Australian Clinical Labs trades on ASX under the ticker symbol "ACL".
2. What is Australian Clinical Labs's stock price today?
One share of ACL stock can currently be purchased for approximately $4.68.
3. How can I contact Australian Clinical Labs?
Australian Clinical Labs's mailing address is 1868-1892 Dandenong Road Clayton VIC 3168 Australia. The company can be reached via phone at 61 3 9538 6777.
4. What is Australian Clinical Labs's official website?
The official website of Australian Clinical Labs is https://www.clinicallabs.com.au.
5. Which share registry manages Australian Clinical Labs's stock?
Australian Clinical Labs's stock is managed by LINK MARKET SERVICES LIMITED.